|
STOK
|
Stoke Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
PNTG
|
The Pennant Group, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
PGEN
|
Precigen, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
PAHC
|
Phibro Animal Health Corporation
|
0.00%
|
US
|
NASDAQ
|
|
ORGO
|
Organogenesis Holdings Inc.
|
0.00%
|
US
|
NASDAQ
|
|
OCGN
|
Ocugen, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
NOTV
|
Inotiv, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
MGTX
|
MeiraGTx Holdings plc
|
0.00%
|
US
|
NASDAQ
|
|
MDXG
|
MiMedx Group, Inc
|
0.00%
|
US
|
NASDAQ
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
LUNG
|
Pulmonx Corporation
|
0.00%
|
US
|
NASDAQ
|
|
IGMS
|
IGM Biosciences, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
GTHX
|
G1 Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
GOSS
|
Gossamer Bio, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
EOLS
|
Evolus, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
BFLY
|
Butterfly Network, Inc.
|
0.00%
|
US
|
NYSE
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
ATAI
|
ATAI Life Sciences N.V.
|
0.00%
|
US
|
NASDAQ
|
|
AMRX
|
Amneal Pharmaceuticals, Inc.
|
0.00%
|
US
|
NYSE
|
|
ALXO
|
ALX Oncology Holdings Inc.
|
0.00%
|
US
|
NASDAQ
|